I work in a clinical microbiology lab.
PCR has been around for decades now and while it completely changed how we test for viruses and fastidious organisms (bugs that are difficult grow) it hasn't changed the fact we still need to culture bacteria in order to test their susceptibility to antibiotics...which is the primary information Drs want to know when sending a microbiology sample off to the pathology lab.
There are numerous technologies that 'threaten' the current practices in the micro lab but it will be decades before we have to stop actually culturing bacteria from samples.
APAS has a role for a while to come. The issue is the company grossly overstated its potential market.
- Forums
- ASX - By Stock
- Ann: MRSA Analysis Module CE Mark Registration
I work in a clinical microbiology lab.PCR has been around for...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.20M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $8.542K | 657.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 227894 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 570000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 227894 | 0.013 |
4 | 373332 | 0.012 |
3 | 164499 | 0.011 |
4 | 1050000 | 0.010 |
1 | 62000 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 570000 | 1 |
0.015 | 108655 | 1 |
0.016 | 294780 | 1 |
0.017 | 160974 | 2 |
0.018 | 600000 | 6 |
Last trade - 12.51pm 03/07/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online